Metodo para entrega eficiente de moleculas terapeuticas a celulas CXCR4+

Desarrollado por: Instituto de Investigación Biomédica Sant Pau (IIB Sant Pau)

Descripción

The invention relates to conjugates comprising a targeting moiety specific for the CXCR4 based on the polyphemusin-derived peptide and a therapeutic or imaging agent. The invention relates as well to the application of said conjugates for the therapy and diagnostics which require the specific targeting to CXCR4+cell. This technology provides for the first time a promising, highly targeted drug delivery system for the treatment of colorectal tumor cells.

Aplicaciones

Modular protein approaches to nanocarriers for pharmaceuticals permits a treatment with a precise adjustmen of the dosage regimen, allowing a considerably important reduction of side effects.

Estado de protección

Patente PCT/EP2012/050513

Cooperación que se desea

 Co-development and license agreement

Responsable: Miriam Ors

Contacto (Tel./mail): m(ELIMINAR)ors(ELIMINAR)@santpau.cat   / 93 553 78 69

Estado:
En busca de codesarrolladores, En desarrollo, Transferible
Tecnología sanitaria:
Biotecnología y Diagnóstico Molecular (proteómica, genómica, etc...)